Keywords: phytopharm, h1, loss, widens, l3, 6m, uk
Phytopharm's H1 2006 loss widens to L3.6M
Article | 15 May 2006
UK plant-based pharmaceutical group Phytopharm says that its loss for the six months to February 28, 2006, deepened to L3.6 million ($6.7 million) ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
